Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC to license Rhinomed's nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogues and derivatives.
Pnina Feldman's Queensland Bauxite Limited (ASX:QBL) has announced today that QBL is undertaking a significant transformation of the Company from a mining exploration company with a Medical Cannabis subsidiary to a new major global Cannabis player through a 100% merger of its 55% owned subsidiary, Medical Cannabis Limited and the new 100% acquisition of Medcan Australia.
The Board of Queensland Bauxite Limited (ASX:QBL) is excited to announce that the Company and its subsidiary, Medical Cannabis Limited have entered into a legally binding heads of agreement to acquire a 100% interest in Medcan Australia Pty Ltd.
Oventus Medical Ltd (ASX:OVN) is pleased to provide a copy of its latest newsletter for investors.
The Board of Queensland Bauxite Limited (ASX:QBL) is delighted to announce that the ASX has approved the Company's Announcement to be released. The Company intends to release the announcement on Thursday 21 June 2018. QBL will recommence trading on the ASX following the release of the Announcement.
Nanollose Limited (ASX:NC6) is pleased to announce that, following the recent successful pilot scale production of its Plant-Free NullarborTM fibre, Mr Gary Cass will increase his involvement in the Company's research and development. From 11 June 2018 Mr Cass will commence a full-time executive role within Nanollose and transition from non-executive director to executive director of the Company.
Oventus Medical Ltd (ASX:OVN) is pleased to attach a copy of the presentation that Founder and Clinical Director, Dr Chris Hart will deliver to investors this morning at the Thorney Sydney Investment Forum.
